XML 15 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Revenue:        
Product sales $ 13,327,525 $ 11,049,840 $ 30,708,750 $ 30,580,889
Development revenue 1,485,091 2,101,203 7,894,640 6,466,974
Licensing revenue 19,486 38,618 1,057,204 128,040
Royalties 220,295 289,102 815,421 850,022
Total revenue 15,052,397 13,478,763 40,476,015 38,025,925
Cost of revenue:        
Cost of product sales 7,600,180 7,206,280 16,681,689 18,670,363
Cost of development revenue 922,717 827,441 3,677,363 3,457,197
Total cost of revenue 8,522,897 8,033,721 20,359,052 22,127,560
Gross profit 6,529,500 5,445,042 20,116,963 15,898,365
Operating expenses:        
Research and development 3,289,445 5,958,550 9,535,089 15,554,599
Selling, general and administrative 8,185,865 5,622,937 23,013,130 20,240,635
Total operating expenses 11,475,310 11,581,487 32,548,219 35,795,234
Operating loss (4,945,810) (6,136,445) (12,431,256) (19,896,869)
Interest expense (625,938)   (794,129)  
Other income 119,227 15,462 197,003 58,313
Net loss $ (5,452,521) $ (6,120,983) $ (13,028,382) $ (19,838,556)
Basic and diluted net loss per common share $ (0.03) $ (0.04) $ (0.08) $ (0.13)
Basic and diluted weighted average common shares outstanding 156,400,702 155,060,811 155,851,639 154,952,060